REDEFINE 1 analyses presented at The Menopause Society 2026 meeting found mean weight loss of 23.1% to 26.7% across pre-, peri-, and postmenopausal women.
|Articles|June 16, 2022
Daily OTC Pearl: Lung Support Formula
Author(s)Saro Arakelians, PharmD
Lung Support Formula is comprised of natural extracts to help promote lung health.
Advertisement
OTC/Lifestyle Pearl of the Day: Lung Support Formula
Indication: Lung Support Formula is comprised of natural extracts to help promote lung health.
Insight:
- Targeted support for lung health every day and while quitting smoking.
- This natural extract blend supports lung detoxification and comfort.
- Helps to encourage healthy mucous production to remove germs from the respiratory tract.
- Soothes uncomfortable inflammation and promotes proper lung function.
- Contains vitamin A, C, magnesium, and zinc.
- Directions: Take 1 capsule 2 times per day Do not take with other medications or within 1 hour of other medications.
Source:
Advertisement
Related to this article
Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.
Sea buckthorn is a commonly used herbal for respiratory health—US pharmacists are knowledgeable in educating patients on herbals, especially during the cold season.
Community pharmacies are access points, safe places, and sources of stability when everything else feels uncertain.
In the phase 3 B-Well trials, about 1 in 5 adults reached functional cure after a fixed course, but a boxed warning makes monitoring key for pharmacists.
Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
The once-nightly drop, previously approved to reverse pupil dilation, met its primary end point in 2 phase 3 trials, with conjunctival hyperemia most common.
Isatuximab on-body injector enables quick, hyaluronidase-free subcutaneous dosing, reducing reactions and easing multiple myeloma clinic workflows.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
2
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
3
FDA Grants Accelerated Approval to Ravulizumab for Proteinuria Reduction in IgA Nephropathy
4
What Pharmacists Should Know About Sea Buckthorn for Respiratory Health
5